26 results
8-K
EX-2.1
QNCX
Quince Therapeutics Inc
24 Jul 23
Entry into a Material Definitive Agreement
7:16am
, a reasonable basis for the FDA to invoke its Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities Policy or any Governmental … investigation by the FDA pursuant to its Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities Policy or any Governmental Authority
8-K
EX-2.1
2saabo6aqmz9z1pab
12 May 22
Entry into a Material Definitive Agreement
5:12pm
8-K
EX-10.1
ogrvmg9i e6xfbcj
23 Dec 21
Entry into a Material Definitive Agreement
5:26pm
10-K
5b8vjk
16 Mar 20
Annual report
4:16pm
424B4
5z3ozwjk9xa6 g6
9 May 19
Prospectus supplement with pricing info
5:14pm
S-1/A
4mkelr
16 Apr 19
IPO registration (amended)
6:04am